02 January 2022>: Clinical Research
Retrospective Study of 573 Patients with Heart Failure Evaluated for Coronary Artery Disease at Toulouse University Center, France
Antoine Deney 1ABCDEF* , Vanessa Nader 12ABCDEF* , Anthony Matta 13ABCDE , Romain Itier 1CDE , Pauline Fournier 1ABCD , Olivier Lairez 1ADF , Nathalie Pizzinat 4ACD , Didier Carrié 1ACD , Frédéric Boal 4ACD , Michel Galinier 1ACD , Oksana Kunduzova 4ACD , Rania Azar 2ACD , Jerome Roncalli 14ABCDEFG*DOI: 10.12659/MSM.934804
Med Sci Monit 2022; 28:e934804
Table 2 The distribution of significant coronary artery disease.
Ischemic heart failure population (N=320) | IHFrEF group (N=270) | IHFpEF group (N=50) | |
---|---|---|---|
Left anterior descending coronary artery | 214 (66.88%) | 182 (67.40%) | 32 (64.00%) |
Right coronary artery | 169 (52.81%) | 146 (54.07%) | 23 (46.00%) |
Circumflex coronary artery | 179 (55.94%) | 152 (56.30%) | 27 (54.00%) |
Single vessel coronary disease | 145 (45.31%) | 118 (43.70%) | 27 (54.00%) |
Two-vessel coronary disease | 106 (33.13%) | 92 (34.07%) | 14 (28.00%) |
Triple-vessel coronary disease | 68 (21.25%) | 59 (21.85%) | 9 (18.00%) |